Antibody‐based therapies in B‐cell lineage acute lymphoblastic leukaemia

E-ISSN： 1600-0609|94|2|99-108

ISSN： 0902-4441

Source： EUROPEAN JOURNAL OF HAEMATOLOGY, Vol.94, Iss.2, 2015-02, pp. : 99-108

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PAX5 alterations in genetically unclassified childhood Precursor B‐cell acute lymphoblastic leukaemia

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 171, Iss. 2, 2015-10 ,pp. : 263-272

John Wiley & Sons Inc

Access to resources Recommend Favorite

PAX5 alterations in genetically unclassified childhood Precursor B‐cell acute lymphoblastic leukaemia

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 7-1048, Iss. 2, 2015-10 ,pp. : 263-272

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Fourth Case of 8p11 Myeloproliferative Disorder Transforming to B-Lineage Acute Lymphoblastic Leukaemia

Acta Haematologica, Vol. 107, Iss. 2, 2002-03 ,pp. : 98-100

Karger

Access to resources Recommend Favorite

A risk score including microdeletions improves relapse prediction for standard and medium risk precursor B‐cell acute lymphoblastic leukaemia in children

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 180, Iss. 4, 2018-02 ,pp. : 550-562

John Wiley & Sons Inc

Access to resources Recommend Favorite

Challenges in monoclonal antibody-based therapies

By Samaranayake Haritha Wirth Thomas Schenkwein Diana Raty Jani Yla-Herttuala Seppo

Annals of Medicine, Vol. 41, Iss. 5, 2009-01 ,pp. : 322-331

Informa Healthcare

Access to resources Recommend Favorite